Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gansu Yuansen Pharmaceutical is a pharmaceutical enterprise located in the High-tech Industrial Development Zone of Lanzhou, China. The company focuses on the production and distribution of chemical drugs and traditional Chinese medicine (TCM) preparations. Its core product line includes treatments for liver diseases, respiratory conditions, and metabolic disorders, with a significant emphasis on GMP-compliant manufacturing. Gansu Yuansen serves as a regional hub for drug supply in Northwest China, maintaining a diverse portfolio of oral solids and liquid formulations. The company's flagship products include Compound Glycyrrhizin and various respiratory medications. It operates integrated facilities for research, development, and large-scale production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gansu Yuansen Pharmaceutical.